We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
+10.7%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$680M
AUM Growth
+$44.3M
Cap. Flow
+$13.8M
Cap. Flow %
2.03%
Top 10 Hldgs %
51.48%
Holding
61
New
16
Increased
14
Reduced
12
Closed
11

Top Buys

Rank Stock Value
1
LJPC
La Jolla Pharmaceutical Company
LJPC
+$14.6M
2
NSTG
NanoString Technologies, Inc.
NSTG
+$12.4M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$10.6M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$10.4M
5
XENT
Intersect ENT, Inc
XENT
+$7.03M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$36.9M
2
ENDP
Endo International plc
ENDP
+$24.4M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$17.7M
4
EXAS
Exact Sciences
EXAS
+$15.6M
5
XRAY icon
Dentsply Sirona
XRAY
+$11.5M

Sector Composition

Rank Sector Weight
1 Healthcare 72.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
51
CALL
Iovance Biotherapeutics
IOVA
$2.23B
– –
-27,500
Closed -$352K
MDWD icon
52
MediWound
MDWD
$183M
– –
-68,157
Closed -$3.29M
MTD icon
53
Mettler-Toledo International
MTD
$26.8B
– –
-11,900
Closed -$6.89M
XERS icon
54
Xeris Biopharma Holdings
XERS
$1.44B
– –
-250,000
Closed -$4.75M
XRAY icon
55
Dentsply Sirona
XRAY
$2.59B
– –
-262,900
Closed -$11.5M
GBT
56
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-80,100
Closed -$3.55M
ENDP
57
CALL
DELISTED
Endo International plc
ENDP
– –
-1,200,000
Closed -$11.3M
ENDP
58
DELISTED
Endo International plc
ENDP
– –
-2,591,573
Closed -$24.4M
ODT
59
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
– –
-93,081
Closed -$2.06M
ZGNX
60
PUT
DELISTED
Zogenix, Inc.
ZGNX
– –
-335,000
Closed -$14.8M
1 2
3

Similar funds

CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Broadfin Capital held 61 positions worth $680M, up 7% from $635M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Broadfin Capital's Q3 2018 filing shows 16 new, 14 increased, 12 reduced and 11 closed positions. Its largest new stake was NanoString Technologies, Inc.: 850,000 shares worth $15.2M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $36.9M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 84% a quarter earlier.

  • Broadfin Capital's largest Q3 2018 buy was NanoString Technologies, Inc.: 850,000 shares worth $15.2M.
  • Broadfin Capital added most to La Jolla Pharmaceutical Company in Q3 2018, an estimated $14.6M increase.
  • Broadfin Capital's biggest Q3 2018 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $36.9M.
  • Broadfin Capital fully exited Endo International plc in Q3 2018, selling an estimated $24.4M.
  • Broadfin Capital's ten largest holdings make up 51% of its $680M portfolio in Q3 2018.
  • Broadfin Capital opened 16 new positions and closed 11 in Q3 2018.
  • Broadfin Capital's portfolio value rose 7% quarter-over-quarter to $680M.

Based on Broadfin Capital's 13F filing for Q3 2018, filed 14 Nov 2018.